CenturyLink Inc. (CTL, Financial), W.W. Grainger Inc. (GWW, Financial), Bed Bath & Beyond Inc. (BBBY, Financial) and OPKO Health Inc (OPK, Financial) have declined to their three-year lows.
CenturyLink Inc. (CTL, Financial) declined to $22.99
The prices of CenturyLink Inc. (CTL, Financial) shares have declined to $22.99 on July 14, which is only 4.6% above the three-year low of $21.94.
CenturyLink Inc. is an American telecommunications company that provides communications and data services to residential, business, governmental and wholesale customers in 37 states. The company operates as a local exchange carrier and internet access provider in U.S. markets and is the third largest telecommunications company in the U.S.
CenturyLink Inc. has a market cap of $12.62 billion; its shares were traded around $22.99 with a P/E ratio of 22.54 and P/S ratio of 0.72. The trailing 12-month dividend yield of CenturyLink Inc. stocks is 9.41%. The forward dividend yield of CenturyLink Inc. stocks is 9.48%. CenturyLink Inc. had an annual average earnings growth of 0.20% over the past 10 years.
On July 10 L CenturyLink Inc. announced that the states of Alaska, Colorado, New York and Pennsylvania recently approved the company’s acquisition of Level 3 Communications Inc. Delaware, Georgia, Hawaii, Maryland, Minnesota, Ohio, Utah, Virginia, West Virginia and the District of Columbia has already approved of the acquisition and the merger has also received regulatory clearance from seven other states.
W.W. Grainger Inc. (GWW, Financial) declined to $171.89
The prices of W.W. Grainger Inc. (GWW, Financial) shares have declined to $171.89 July 14, which is only 2.6% above the 3-year low of $167.44.
W.W. Grainger Inc. is an American Fortune 500 industrial supply company and distribution company. The company is a business to business distributor of products used to maintain, repair and operate facilities. The company has customers in industries including healthcare, manufacturing, government and hospitality.
W.W. Grainger Inc. has a market cap of $10.04 billion; its shares were traded around $171.89 with a P/E ratio of 17.49 and P/S ratio of 1.00. The trailing 12-month dividend yield of W.W. Grainger Inc. stocks is 2.86%. The forward dividend yield of W.W. Grainger Inc. stocks is 3.01%. W.W. Grainger Inc. had an annual average earnings growth of 11.40% over the past 10 years.
On April 18 W.W. Grainger announced financial results for the first quarter 2017. The company reported net sales of $2.5 billion, a 1% increase compared to first quarter 2016. Net earnings for the quarter was $175 million, down 6% versus $187 million during first quarter 2016. Furthermore, earnings per share was $2.93, down 2% versus $2.98 in first quarter 2016.
Bed Bath & Beyond Inc. (BBBY, Financial) declined to $29.18
The prices of Bed Bath & Beyond Inc. (BBBY, Financial) shares have declined to $29.18 July 14, which is only 2.9% above the three-year low of $28.33.
Bed Bath & Beyond Inc. is an American international chain of merchandise retail stores that operate in the United States, Canada and Mexico. The company sells mostly bedroom, bathroom and kitchen products. It has a total of 58,000 employees as of 2014.
Bed Bath & Beyond Inc. has a market cap of $4.22 billion; its shares were traded around $29.18 with a P/E ratio of 6.79 and P/S ratio of 0.35. The trailing 12-month dividend yield of Bed Bath & Beyond Inc. stocks is 1.79%. The forward dividend yield of Bed Bath & Beyond Inc. stocks is 2.05%. Bed Bath & Beyond Inc. had an annual average earnings growth of 13.30% over the past 10 years.
On April 5 Bed Bath & Beyond Inc. reported financial results for the fourth quarter and full year of fiscal 2016. The company reported net earnings of $1.84 per diluted share for the fiscal fourth quarter, compared with $1.91 per diluted share for the fiscal 2015 fourth quarter. Net sales for the fiscal 2016 fourth quarter were $3.5 billion, an increase of approximately 3.4% from net sales of 3.4 billion reported in the fiscal 2015 fourth quarter.
OPKO Health Inc. (OPK, Financial) declined to $6.13
The prices of OPKO Health Inc. (OPK, Financial) shares have declined to $6.13 July 14, which is only 2.3% above the three-year low of $5.99.
OPKO Health is an American pharmaceutical and medical test company. The company is mainly focused on diagnostics and pharmaceuticals, but also develops treatments for secondary hyperparathyroidism. The company has recently finished the patient recruitment for a Phase III trial against insufficiency in Vitamin D. In 2014, it acquired Laboratorio Arama de Uruguay.
OPKO Health Inc. has a market cap of $3.43 billion; its shares were traded around $6.13 with and P/S ratio of 2.80.
On June 7 OPKO Health Inc. announced the extension of its relationship with the University of California Health for genetic, genomic and molecular testing services. The university selected the GeneDx, a business unit of OPKO Health Inc., to supplement its own offering of genetic, genomic and molecular testing services to remain at the forefront of precision medicine.
Disclosure: I do not own stock in any of the companies mentioned in the article.
